High expression of ABCC5 down-regulates ferroptosis by stabilizing SLC7A11 protein and reducing GPX4 depletion, inhibiting lipid peroxidation, and increasing mitochondrial membrane potential (MMP), thereby promoting the development of sorafenib resistance in HCC cells (17). This evidence concerns the gene ABCC5 and hepatocellular carcinoma.